Progyny, Inc. will announce Q1 2026 financial results on May 7, followed by a conference call.
Quiver AI Summary
Progyny, Inc. will release its financial results for the first quarter of 2026 after the market closes on May 7, 2026. A conference call to discuss these results will take place at 4:45 p.m. Eastern Time, with details for U.S. and international participants to join provided in the announcement. An audio replay will be available until May 14, and a live webcast will be accessible on the company's website. Progyny, a leader in women’s health and family building solutions, aims to support individuals' family and health aspirations through innovative benefits, and has received multiple accolades for its growth and workplace culture.
Potential Positives
- Progyny will report its financial results for Q1 2026, indicating active management and transparency with stakeholders.
- The upcoming conference call reflects the company's commitment to engaging with investors and providing updates on its performance.
- Progyny has been recognized with multiple prestigious awards, underscoring its leadership and growth in the women's health and family building solutions sector.
- The press release highlights the company's innovative solutions and focus on improving healthcare outcomes, positioning it favorably in a competitive market.
Potential Negatives
- Delay in reporting financial results may raise concerns among investors about the company's transparency and financial health.
FAQ
When will Progyny announce its Q1 2026 financial results?
Progyny will report its financial results for Q1 2026 on May 7, 2026, after market close.
How can I access the Progyny conference call?
Interested participants can dial 1.866.825.7331 (US) or 1.973.413.6106 (international) to access the conference call.
What is the passcode for the Progyny conference call?
The passcode for the conference call is 265484 for both US and international participants.
Will there be a replay of the conference call?
Yes, an audio replay will be available until May 14, 2026, at designated access numbers.
Where can I find more information about Progyny?
For more information about Progyny, visit their website at www.progyny.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$PGNY Insider Trading Activity
$PGNY insiders have traded $PGNY stock on the open market 10 times in the past 6 months. Of those trades, 1 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $PGNY stock by insiders over the last 6 months:
- PETER ANEVSKI (CHIEF EXECUTIVE OFFICER) purchased 79,500 shares for an estimated $1,930,896
- MARK S. LIVINGSTON (CHIEF FINANCIAL OFFICER) has made 0 purchases and 3 sales selling 21,975 shares for an estimated $560,362.
- ALLISON SWARTZ (EVP, GC) has made 0 purchases and 6 sales selling 10,383 shares for an estimated $206,979.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PGNY Revenue
$PGNY had revenues of $318.4M in Q4 2025. This is an increase of 6.69% from the same period in the prior year.
You can track PGNY financials on Quiver Quantitative's PGNY stock page.
$PGNY Hedge Fund Activity
We have seen 146 institutional investors add shares of $PGNY stock to their portfolio, and 169 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 1,858,195 shares (-12.5%) from their portfolio in Q4 2025, for an estimated $47,718,447
- WELLINGTON MANAGEMENT GROUP LLP added 1,621,688 shares (+260.9%) to their portfolio in Q4 2025, for an estimated $41,644,947
- CITADEL ADVISORS LLC added 1,238,899 shares (+134.4%) to their portfolio in Q4 2025, for an estimated $31,814,926
- MARSHALL WACE, LLP removed 1,072,733 shares (-92.5%) from their portfolio in Q4 2025, for an estimated $27,547,783
- FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ added 859,289 shares (+46.9%) to their portfolio in Q1 2026, for an estimated $14,590,727
- ALLIANZ ASSET MANAGEMENT GMBH added 841,365 shares (+4141.8%) to their portfolio in Q4 2025, for an estimated $21,606,253
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 836,652 shares (+inf%) to their portfolio in Q4 2025, for an estimated $21,485,223
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PGNY Analyst Ratings
Wall Street analysts have issued reports on $PGNY in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citizens issued a "Market Outperform" rating on 01/20/2026
To track analyst ratings and price targets for $PGNY, check out Quiver Quantitative's $PGNY forecast page.
$PGNY Price Targets
Multiple analysts have issued price targets for $PGNY recently. We have seen 7 analysts offer price targets for $PGNY in the last 6 months, with a median target of $28.0.
Here are some recent targets:
- Glen Santangelo from Barclays set a target price of $23.0 on 03/20/2026
- Richard Close from Canaccord Genuity set a target price of $19.0 on 03/11/2026
- David Larsen from BTIG set a target price of $30.0 on 03/05/2026
- Jailendra Singh from Truist Securities set a target price of $28.0 on 03/02/2026
- Scott Schoenhaus from Keybanc set a target price of $28.0 on 03/02/2026
- Constantine Davides from Citizens set a target price of $30.0 on 01/20/2026
- Lisa Gill from JP Morgan set a target price of $26.0 on 11/11/2025
Full Release
NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended March 31, 2026, after the close of the market on Thursday, May 7, 2026.
The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.
Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.
An audio replay of the call will be available through Thursday, May 14, 2026, and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.
A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com .
About Progyny
Progyny (Nasdaq: PGNY) is a global leader in women's health and family building solutions, trusted by the nation's leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, INC. 5000, INC. Power Partners and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com .
For Further Information, Please Contact:
Investors:
James Hart
[email protected]
Media:
Alexis Ford
[email protected]
